The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence.
The diploid IR6 gene (ORF 67) of equine herpesvirus type 1 (EHV-1) is absent in the modified live EHV-1 vaccine strain RacH and is present in a mutated form in the avirulent EHV-1 strains RacM24 and RacM36, such that the IR6 protein fails to form the typical rod-like structures observed for wild-type EHV-1 RacL11. To assess the role of the IR6 protein in EHV-1 replication and virulence, two recombinant RacH viruses, HIR6-1 and HIR6-2, that harbor a single copy of the wild-type IR6 gene were engineered and characterized. It was shown that: (i) HIR6-1 or HIR6-2 virus encoded for an IR6 protein that was capable of forming the rod-like structures typical of cells infected with the wild-type virulent virus strain RacL11. (ii) Whereas the avirulent EHV-1 strains RacH and RacM36 are temperature-sensitive (in that virus replication at 40 degrees versus that at 37 degrees was reduced by as much as 7,500-fold), the HIR6-1 and HIR6-2 viruses, like RacL11 virus, were capable of significant replication at the elevated temperature. (iii) Electron microscopic analyses revealed that cells infected with the HIR6-1 or HIR6-2 virus, like those infected with virulent RacL11 virus, produced and released comparable numbers of virus particles at both 37 and 40 degrees. In cells infected with the RacH virus at 40 degrees, however, release of extracellular particles was inhibited by greater than 90% and relatively few of the particles were enveloped. (iv) Infections of BALB/cA mice revealed that both the HIR6-1 and HIR6-2 viruses, unlike the parent RacH virus, were as virulent as the wild-type RacL11 strain as judged by the criteria of body weight loss, development of clinical signs of EHV-1 infection, virus titers in the lung, and ability to cause viremia. These findings and those of our recent studies indicate that the IR6 protein is a major determinant of EHV-1 virulence and that the IR6 protein may play a role in virus maturation and/or egress.
Osterrieder
N
N
Institute for Medical Microbiology, Infectious and Epidemic Diseases, Ludwig-Maximilians-University Munich, Germany. klaus.osterrieder@lrz.unimuenchen.de
Neubauer
A
A
Brandmüller
C
C
Kaaden
O R
OR
O'Callaghan
D J
DJ
D000818:Animals; D002460:Cell Line; D005260:Female; D006566:Herpesviridae Infections; D004861:Herpesvirus 1, Equid / Q000235:genetics / Q000254:growth & development* / Q000472:pathogenicity; D006736:Horses; D051379:Mice; D008807:Mice, Inbred BALB C; D011995:Recombination, Genetic; D012692:Serial Passage; D013696:Temperature; D014764:Viral Proteins / Q000096:biosynthesis / Q000502:physiology*; D014771:Virion / Q000378:metabolism; D014774:Virulence / Q000235:genetics; D014779:Virus Replication
D014764:Viral Proteins; C078423:IR6 protein, Equine herpesvirus 1